Stevanato Group S.p.A STVN
NYSE STVN
$15.80 +1.49 (+10.41%)
At close: Nov 13, 2026 · 4:00 PM EST

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)

Updated

Stevanato Group S.p.A (STVN) recorded EBITDA Margin of 26.35% in the quarter ended Sep 30, 2026, up 1.78 percentage points from 24.57% a year earlier and up 5.41 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Stevanato Group S.p.A's EBITDA Margin came in at 24.61% as of Sep 30, 2026, up 0.75 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 24.22%, up 2.32 percentage points from the prior year.

  • Annual EBITDA Margin has a five-year change of +0.48 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBITDA Margin came in at 21.90% in the year ended Dec 31, 2024 (-3.82 pp), 25.72% in the year ended Dec 31, 2023 (-0.43 pp), 26.15% in the year ended Dec 31, 2022 (+0.25 pp) and 25.90% in the year ended Dec 31, 2021 (+2.16 pp).
  • Quarterly EBITDA Margin has ranged from 18.81% in the quarter ended Jun 30, 2024 to 27.45% in the quarter ended Dec 31, 2022 over the past five years.
  • On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +1.43 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 6.05 percentage points in the quarter ended Sep 30, 2022, against a drop of 6.41 percentage points in the quarter ended Jun 30, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at 20.94% (quarter ended Jun 30, 2026), 23.17% (quarter ended Mar 31, 2026) and 27.33% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 25.44%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 20.09%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 30.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 25.90%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 25.55%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 23.14%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 20.05%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 9.79%
10 Stevanato Group S.p.A 4.78 Bn 4.32 Bn 109.24 Mn 26.35%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 26.35%
Jun 30, 2026 20.94%
Mar 31, 2026 23.17%
Dec 31, 2025 27.33%
Sep 30, 2025 24.57%
Jun 30, 2025 22.47%
Mar 31, 2025 21.53%
Dec 31, 2024 26.17%
Sep 30, 2024 21.40%
Jun 30, 2024 18.81%
Mar 31, 2024 19.90%
Dec 31, 2023 26.22%
Sep 30, 2023 26.42%
Jun 30, 2023 25.22%
Mar 31, 2023 24.80%
Dec 31, 2022 27.45%
Sep 30, 2022 26.17%
Jun 30, 2022 25.51%
Mar 31, 2022 25.05%
Dec 31, 2021 25.19%
API Access

Stevanato Group S.p.A EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=STVN&period=max&api_key=YOUR_API_KEY